31-05-243

An Open-Label Rollover Study for Subjects with Schizophrenia Completing ABILIFY® (Aripiprazole) Clinical Study 31-03-241

Study Information Study ID

31-05-243/NCT01001702

Full Study Title

An Open-Label Rollover Study for Subjects with Schizophrenia Completing ABILIFY® (Aripiprazole) Clinical Study 31-03-241

Active Ingredient / Drug Information

Aripiprazole/Tablet, Oral

Disease

Schizophrenia

Phase

CSR Summary